RobertHerndonMD

PubMed

• Letter to the Editor: Importance of Early Treatment of Multiple Sclerosis Exacerbations.
  Robert M. Herndon> ;International Journal of MS Care. 2019 Jul 1
• 83 citations
  Is multiple sclerosis a length-dependent central axonopathy? The case for therapeutic lag and the asynchronous progressive MS hypotheses
  Gavin Giovannoni, Gary Cutter, Maria Pia Sormani, Shibeshih Belachew, Robert Hyde, Harold Koendgen, Volker Knappertz, Davorka Tomic, David Leppert, Robert M. Herndon, ...> ;Multiple Sclerosis and Related Disorders. 2017 Feb 1
• 19 citations
  Differentiation of Neuromyelitis Optica from Multiple Sclerosis on Spinal Magnetic Resonance Imaging
  Saurabh Lalan, Majid Khan, Bruce Schlakman, Alan D. Penman, Joseph L. Gatlin, Robert M. Herndon> ;International Journal of MS Care. 2012 Dec 28
• 14 citations
  Gender effects on intramuscular interferon beta-1a in relapsing-remitting multiple sclerosis: analysis of 1406 patients
  Richard A. Rudick, Ludwig Kappos, Revere P. Kinkel, Michel Clanet, JT Phillips, Robert M. Herndon, Alfred Sandrock, Frederick Munschauer> ;Multiple Sclerosis. 2011 Mar 1
• 162 citations
  Imbalance in multiple sclerosis: A result of slowed spinal somatosensory conduction
  Michelle Cameron, Fay B. Horak, Robert R. Herndon, Dennis Bourdette> ;Somatosensory & Motor Research. 2008 Jan 1
• 94 citations
  Defining and diagnosing involuntary emotional expression disorder.
  Jeffrey L. Cummings, David B. Arciniegas, Benjamin Rix Brooks, Robert M. Herndon, Edward C. Lauterbach, Erik P. Pioro, Robert G. Robinson, Douglas W. Scharre, Randolph...> ;CNS Spectrums. 2006 Jun 1
• 9 citations
  Multiple sclerosis mimics.
  Robert M. Herndon> ;Advances in Neurology. 2006 Jan 1
• 54 citations
  Eight-year immunogenicity and safety of interferon beta-1a-Avonex treatment in patients with multiple sclerosis.
  Robert M. Herndon, Richard A. Rudick, Frederick Munschauer, Michele Mass, Andres M. Salazar, Michael E. Coats, Robert Labutta, John R. Richert, Stanley Cohan, Claude P...> ;Multiple Sclerosis. 2005 Aug 1
• 20 citations
  Review of mitoxantrone in the treatment of multiple sclerosis.
  Douglas Jeffery, Robert M. Herndon> ;Neurology. 2004 Dec 28
• 41 citations
  Identifying and treating patients with suboptimal responses
  Bruce A. Cohen, Omar Khan, Douglas Jeffery, K. Bashir, Syed A. Rizvi, Edward Fox, Mark A. Agius, Rifaat Bashir, T. E. Collins, Robert M. Herndon, P. Kinkel, Daniel D. ...> ;Neurology. 2004 Dec 28
• 6 citations
  Medical Hypothesis: Why Secondary Progressive Multiple Sclerosis Is a Relentlessly Progressive Illness
  Robert M. Herndon> ;Archives of Neurology. 2002 Feb 1
• 1 citations
  Impact of interferon beta-1a on neurologic disability in relapsing multiple sclerosis. 1997.
  R A Rudick, D E Goodkin, L D Jacobs, D L Cookfair, R M Herndon, J R Richert, A M Salazar, J S Fischer, C V Granger, J H Simon, J J Alam, N A Simonian, M K Campion, D M...> ;Neurology. 2001 Dec 1
• 128 citations
  Neuropsychological effects of interferon beta-1a in relapsing multiple sclerosis. Multiple Sclerosis Collaborative Research Group.
  J. S. Fischer, Roger L. Priore, Lawrence Jacobs, Diane Cookfair, Richard A. Rudick, Robert M. Herndon, Richert, Andres M. Salazar, Donald E. Goodkin, Carl V. Granger, ...> ;Annals of Neurology. 2000 Dec 1
• 104 citations
  A longitudinal study of T1 hypointense lesions in relapsing MS: MSCRG trial of interferon β-1a
  Jack H. Simon, Julia M. Lull, Lawrence Jacobs, Richard A. Rudick, Diane Cookfair, Robert M. Herndon, John R. Richert, Andres M. Salazar, Jeanelle Sheeder, D. E. Miller...> ;Neurology. 2000 Jul 25
• 1 citations
  Interferons in the treatment of multiple sclerosis: errors and misrepresentations.
  Robert M. Herndon> ;Archives of Neurology. 2000 Mar 1
• 17 citations
  Selecting relapsing remitting multiple sclerosis patients for treatment: The case for early treatment
  Richard A. Rudick, Andrew D. Goodman, Robert M. Herndon, Hillel Panitch> ;Journal of Neuroimmunology. 1999 Jul 1
• 254 citations
  A longitudinal study of brain atrophy in relapsing multiple sclerosis
  Jack H. Simon, Lawrence Jacobs, M. Campion, Richard A. Rudick, Diane Cookfair, Robert M. Herndon, John R. Richert, Andres M. Salazar, J. S. Fischer, Donald E. Goodkin,...> ;Neurology. 1999 Jul 1
• 7 citations
  Is Alexander's disease a nosologic entity or a common pathologic pattern of diverse etiology?
  Robert M. Herndon> ;Journal of Child Neurology. 1999 May 1
• 2 citations
  Interferon β treatment for multiple sclerosis
  Robert M. Herndon> ;Lancet. 1999 Feb 6
• 80 citations
  Cerebrospinal fluid abnormalities in a phase III trial of Avonex® (IFNβ-1a) for relapsing multiple sclerosis
  Richard A. Rudick, Diane Cookfair, N. A. Simonian, Richard M. Ransohoff, John R. Richert, Lawrence Jacobs, Robert M. Herndon, Andres M. Salazar, J. S. Fischer, Carl V....> ;Journal of Neuroimmunology. 1999 Jan 1
• 8 citations
  Interferons should be used to treat most patients with MS.
  Robert M. Herndon, Lawrence Jacobs> ;Archives of Neurology. 1998 Dec 1
• 21 citations
  Comparing the ability of various compositive outcomes to discriminate treatment effects in MS clinical trials
  Donald E. Goodkin, Roger L. Priore, K. E. Wende, M. Campion, Dennis Bourdette, Robert M. Herndon, J. S. Fischer, Lawrence Jacobs, Diane Cookfair, RA Rudick, John R. Ri...> ;Multiple Sclerosis. 1998 Dec 1
• 6 citations
  Treatment of multiple sclerosis with the interferon-betas: comparative risks and benefits.
  Robert M. Herndon> ;Biodrugs. 1998 Dec 1
• 257 citations
  Incidence and significance of neutralizing antibodies to interferon beta-1a in multiple sclerosis
  Richard A. Rudick, N. A. Simonian, J. A. Alam, M. Campion, James Scaramucci, Wendy Jones, Michael E. Coats, Donald E. Goodkin, Bianca Weinstock-Guttman, Robert M. Hern...> ;Neurology. 1998 May 1
• 160 citations
  Impact of interferon beta-1a on neurologic disability in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG).
  R A Rudick, D E Goodkin, L D Jacobs, D L Cookfair, R M Herndon, J R Richert, A M Salazar, J S Fischer, C V Granger, J H Simon, J J Alam, N A Simonian, M K Campion, D M...> ;Neurology. 1997 Aug 1
• Join now to see all

Journal Articles

• Differentiation of Neuromyelitis Optica on Spinal Magnetic Resonance Imaging  
  Lalan, Surabh, Khan, Majid, Schlakman Bruce, Penman, Alan, Gatlin Joseph and Herndon, Robert, International J. of MS Care, 1/1/2012
• Natalizumab plus interferon beta-1a reduces lesion formation in relapsing multiple sclerosis  
  Radue EW, Stuart WH, Calabresi PA, Confavreux C, Galetta SL, Rudick RA, Lublin FD, Weinstock-Guttman B, Wynn DR, Fisher E, Papadopoulou A, Lynn F, Panzara MA, Sandrock..., J Neurol Sci, 1/15/2010
• Defining and diagnosing involuntary emotional expression disorder  
  Cummings, JL, Arciniegas DB, Brooks BR, Herndon RM. Lauterbach EC, Pioro EP, Robinson RG, Scharre DW, Schiffer RB, Weintraub D, Spectrums, CNS Spectrum, 1/1/2006
• Pseudobulbar affect in the clinical setting  
  Herndon, R.M., PBA Update, 1/1/2005
• Identifying and Treating Patients with Suboptimal Responses  
  Cohen BA, Khan O, Jeffery DR, Bashir K, Rizvi S, Fox E, Agius M, Bashir R, Collins TE, Herndon R, Kinkel P, Mikol d, Picone MA, Rivera V, Tornatore C, Zwibel H, Neurology, 1/1/2004
• Review of mitoxantrone in the treatment of Multiple Sclerosis  
  Jeffery DR, Herndon RM, Neurology, 1/1/2004
• Why Secondary Progressive Multiple Sclerosis is a Relentlessly Progressive Illness?  
  Herndon, RM, Arch. Neurol, 1/1/2002
• Report of a Consensus Panel on the New Internationl Panel Guidelines for Diagnosis of Multiple Sclerosis  
  Herndon RM, Coyle PK, Murray TJ, Wolinsky JS, for the consensus panel, International Journal of MS Care, 1/1/2002
• Osteoporosis in Multiple Sclerosis: a Frequent, Serious, and Under-Recognized Problem  
  Herndon, RM, Mohandas N, Int. J. MS Care, 1/1/2000
• Neuropsychological Effects of Interferon Beta-1a in relapsing Multiple Sclerosis  
  Fischer JS, Priore RL, Jacobs LD, Cookfair DL, Rudick RA, Herndon RM, Richer JR, Salazar AM, Goodkin DE, Granger CV, Simon JH, Grafman JH, Lezak MD, O’Reilly-Hovey KM..., Ann. Neurol, 1/1/2000
• A longitudinal study of T1 hypointense lesions in relapsing MS: MSCRG trial of interferon beta-1a  
  Simon JH, Lull J, Jacobs LD, Rudick RA, Cookfair DL, Herndon RM, Richert JR, Salazar AM, Sheeder J, Miller D, McCabe K, Serra A, Campion MK, Fischer JS, Goodkin DE, Si..., Neurolog, 1/1/2000
• Interferons in the treatment of multiple sclerosis: errors and misreprensentations  
  Herndon RM, Arch. Neurol, 1/1/2000
• Interferon beta treatment for multiple sclerosis (Commentary on two recent MS clinical trials)  
  Herndon, RM, Lancet, 1/6/1999
• Selecting relapsing remitting multiple sclerosis patients for treatment: The case for early treatment  
  Rudick, R.A. Goodman A, Herndon RM and Panitch HS, J. Neuroimmunol, 1/1/1999
• Results of an Ongoing, Open-Label, Safety-Extension Study of Interferon beta-1a (AVONEX) Treatment in Multiple Sclerosis  
  Herndon RM Jacobs LD, Coats ME, Goodkin DE, Mass MK Richert KR, Rudick RA, Waubant EL, Weinstock-Guttman B, Scaramucci JO, Burnett BK, Jones WE, Simonian NA, International J. Multiple Sclerosis Care, 1/1/1999
• Fatigue in Multiple Sclerosis  
  Herndon, RM, Int. J. MS Care, 1/1/1999
• Is “Alexander’s Disease” a nosological entity or a common pathological pattern of diverse etiology  
  Herndon, R.M, J. Child Neurol, 1/1/1999
• A Longitudinal study of brain atrophy in relapsing multiple sclerosis  
  Simon JH, Jacobs LD, Campion MK, Rudick RA, Cookfair DL, Herndon RM, Richer JR, Salazar AM, Fischer JS, Goodkin DE, Simonian N, Choi K, Lajaunie M, Meyer MJ, Miller DE..., Neurol, 1/1/1999
• Comparing the ability of various compositive outcomes to discriminate treatment effects in MS clinical trials  
  Goodkin DE, Priore RL, Wende KE, Campion M, Bourdette DN, Herndon RM, Fischer JS, Jacobs LD, Cookfair DL, Rudick RA, Richert JR, Salazar AM, Granger CV, Simon JH, Ala..., Multiple Sclerosis, 1/1/1999
• Interferon beta-1a ---(Avonex) in Patients with Multiple Sclerosis:Efficacy and Safety analysis  
  R.M. Herndon, MD; M.E. Coats, MD; D.E. Goodkin, MD; E.L. Waubant, MD; M.K. Mass, MD; J.R. Richert, MD; R.A. Rudick, MD; B. Weinstock-Guttman, MD; N.A. Simonian, MD; M...., Int. J. MS Care, 1/1/1999
• Cerebrospinal fluid abnormalities in a phase III trial of Avonex (IFNbeta-1a) for relapsing multiple sclerosis  
  Rudick RA, Cookfair DL, Simonian NA, Ransohoff RM, Richert JR, Jacobs LD, Herndon RM, Salazar AM, Fischer JS, Granger CV, Goodkin DE, Simon JH, Bartoszak DM, Bourdette..., J. Neuroimmunol, 1/1/1999
• Interferons Should Be Used to Treat Most Multiple Sclerosis Patients  
  Herndon, R.M. and Jacobs, L.D., Arch. Neurol, 1/1/1998
• Treatment of Multiple Sclerosis with the Interferon-betas: Comparative risks and benefits  
  Herndon, R.M., Biodrugs, 1/1/1998
• Incidence and significance of Neutralizing antibodies to interferon beta-1a in multiple sclerosis  
  Rudick, R.A., Simonian, N.A., Alam, J.A., Campion,k M.K., Scaramucci, J.O., Jones W, Coats M.E. Goodkin D.E., Wenstock-Guttman, B., Herndon, R.M., Mass, M.K., Richert ..., Neurology, 1/1/1998
• Magnetic resonance studies of intramuscular interferon beta-1a for relapsing multiple scrlerosis  
  Simon JH, Jacobs LD, Campion M, Wende K, Simonian N, Cookfair DL, Rudick RA, Herndon RM, Richert JR, Salazar AM, Alam JJ, Fischer JS, Goodkin DE, Granger CV, Lajaunie ..., Ann. Neurol, 1/1/1998
• Join now to see all

Books/Book Chapters

• Multiple Sclerosis, a Primer 
  Chapter: Outcome Measures in Multiple Sclerosis 
  Herndon, R.MEditors: Vickery, Barbara.Oxford Univ. Press, New York, NY2011
• Handbook of Neurological Rating Scales 
  Editors: Herndon, R.M. (Ed.).Demos Publications, New York, NYEdition 2nd,2006
• Multiple Sclerosis for the Practicine Neurologist. Seminars in Clinical Neurology 
  Chapter: Multiple Sclerosis Scales 
  Herndon, R.M2006
• Adv. Neurol 
  Chapter: Multiple Sclerosis Mimics 
  Herndon, R.M.2006
• Handbook of Neurological Rating Scales 
  Chapter: Multiple Sclerosis 
  Herndon, R.M. and Greenstein J.Editors: Herndon, R.M.Demos Publications, New York, NY2005
• Handbook of Neurological Rating Scales 
  Chapter: Scales for the Assessment of Ataxia 
  Herndon, RM.Editors: Herndon, R.M..Demos Publications, New York, NY2005
• Handbook of Neurological Rating Scales 
  Chapter: Generic and General Use Scales 
  Herndon, R.M.Editors: Herndon, R.M..Demos Publications, New York, NY2005
• Handbook of Neurological Rating Scales 
  Chapter: Peripheral Neuropathy and Pain Scales 
  Herndon, RMEditors: Herndon, R.M..Demos Publications, New York, NY2005
• Basic Neurological Life Support 
  Chapter: Spinal Cord Emergency Conditions 
  Herndon, R.M.Editors: Herndon, R.M..B.C. Decker Inc, Ontario, Canada2004
• Multiple Sclerosis: Immunology, Physiology and Pathology 
  Editors: Herndon, R.M. (Ed).Demos Publications, New York, NY2003
• Multiple Sclerosis: Immunology, Physiology and Pathology 
  Chapter: Astrocytes: Morphology and Function 
  Herndon, R.M.Editors: Herndon, R.M..Demos Publications, New York, NY2003
• Multiple Sclerosis: Immunology, Physiology and Pathology 
  Chapter: Pathology of Multiple Sclerosis and its Variants 
  Herndon, R.M.Editors: Herndon, R.M..Demos Publications, New York, NY2003
• Multiple Sclerosis: Immunology, Physiology and Pathology 
  Chapter: Mechanisms of Repair, Adaptation and Recovery of Function in Multiple Sclerosis 
  Herndon, R.M.Editors: Herndon, R.M..Demos Publications, New York, NY2003
• Drug Treatment of Multiple Sclerosis 
  Chapter: Treatment of Multiple Sclerosis with the Interferon-betas: Comparative risks and benefits 
  Herndon, R.M.Editors: Wagstaff, A.Adis International, Philadelphia, PA2000
• Clinical Neurology 
  Chapter: Demyelinating Disorders 
  Rudick, R.A., Ransohoff, R and Herndon, R.M.Editors: Joynt, R.J. and Griggs R.C...B. Lippincott Company, Philadelphia, PA1998
• Handbook of Neurological Rating Scales 
  Editors: Herndon, R.M. (Ed.).Demos Publications, New York, NY1997
• Interferons 
  Chapter: Interferons in Multiple Sclerosis 
  Herndon, R.MEditors: Anthony Reder.Marcel Dekker, New York, NY1997
• Handbook of Neurological Rating Scales 
  Chapter: Introduction to Clinical Neurological Scales 
  Herndon, R.M.Editors: Herndon, R.M..Demos Publications, New York, NY1997
• Handbook of Neurological Rating Sc 
  Chapter: Multiple Sclerosis 
  Herndon, R.M. and Goodkin, D.E.Editors: Herndon, R.M..Demos Publications, New York, NY1997
• Handbook of Neurological Rating Scales 
  Chapter: Introduction to Clinical Neurologic Scales 
  Herndon, R.M., Cutter GEditors: Herndon, R.M..Demos Publications, New York, NY1997
• Multiple Sclerosis: The Questions You Have, The Answers You Need 
  Chapter: Treatment Issues 
  Miller, A.E. and Herndon, R.M.Editors: Rosalind C. Kalb.1996
• Conn's Current Therapy 
  Chapter: Treatment of Multiple Sclerosis 
  Herndon, R.M.1995
• Multiple Sclerosis; Current Status of Research and Treatment 
  Editors: Herndon, R.M. and Seil, F.J. (Eds.).Demos Publications, New York, NY1994
• Multiple Sclerosis; Current Status of Research and Treatment 
  Chapter: Remyelination in the nervous system in animals and man 
  Herndon, R.MEditors: Herndon, R.M. and Seil, F.J..1994
• Multiple Sclerosis; Current Status of Research and Treatment 
  Chapter: Changing Pattern of Misdiagnosis in Multiple Sclerosis 
  Herndon, R.M.Editors: Herndon, R.M. and Seil, F.J..1994
• Join now to see all

Abstracts/Posters

• MRI Signal Abnormalities of the Anterior Visual Pathway in Neuromyelitis Optica
  Juebin Huang, MD, PhD, Shoba Jayaram, MD, Robert M. Herndon, MD, James J. Corbett, MD, AAN, Annals of Neurol, 1/1/2014
• Typical and atypical Initial Presntation of Neuromyelitis Optica. A Retrospective Study
  Huang J, Chaudhry BZ, McDonald KR, Vedanarayanan VV, Parker CC, Corbett JJ, Herndon RM, Ann. Neurol, Neurology, 1/1/2014
• The Spectrum of Brain MRI abnormalities in Neuromyelitis Optica Spectrum Disorders
  Huang J, Chaudhry BZ, McDonald KR, Vedanarayanan VV, Parker CC, Corbett JJ, Herndon RM, Neurology, 1/1/2014
• The Vaccine Panic that Wasn’t
  Herndon, RM, Am. Acad. Neurology, 1/1/2009
• Balance Problems in Multiple Sclerosis
  Cameron M. Horak F, Herndon, R, Am. Acad. Neurology, 1/1/2007
• Cocaine as a risk factor in cerebral hemorrhage and ischemic stroke
  Si, Xiahong and Herndon, RM, Neurology, 1/1/2006
• Electron microscopic studies of CSF revisited
  Herndon, RM, Consortium of Multiple Sclerosis Centers annual meeting, 1/1/2003
• Eight-year experience with interferon beta-1a in subjects with multiple sclerosis
  Herndon RM, Al-sabbagh AAL, Bennett R, Riester K, Zhang H, Toal M, Consortium of Multiple Sclerosis Centers annual meeting, 1/1/2003
• Herndon, RM, Coats M, Goodkin D, Mass M, Richert J, Rudick RA, Weinstock-Guttman B, Simonian NA, Campion M, Scaramucci J, Alam JJ, Jacobs L, Annals Neurol, 1/1/1997
• Results of a Phase III Trial of IM Recombinant Beta Interferon at Treatment for MS
  Jacobs, L.D. Cookfair, D.L., Rudick, R.A., Herndon, R.M., Richert, J.R., Salazar, A.M., Fischer, J.S., Goodkin, D.E. Granger, C. Simon, J. and the MS collaborative st..., Am. Neurol. Assn. Mtg, 1/1/1994
• Natural history of MS by quantitative MRI
  Simon, J., Jacobs, L., Rudick, R., Herndon, R., Salazar, A. and the Multiple Sclerosis Collaborative Group (MSCRG), ASNR30th Annual Meeting, St. Louis, MO, 1/31/1992
• Different categories of postural dyscontrol in multiple sclerosis
  Herndon, R.M., Pratt, C.A., and Horak, F.B, The American Neurological Association Meetings, 1/13/1990
• White matter changes following treatment of experimental hyponatremia
  Herndon, R.M. and Sterns, R, Society of Experimental Neuropathology Meetings, 1/13/1990
• Cognitive deficits and emotional dysfunction in Multiple Sclerosis
  Herndon, R.M, Archives of Neurology, 1/1/1990
• Myelination of axons within ara C treated cerebellar explants by transplanted purified oligodendrocytes
  Seil, F.J., Johnson, M.L., Saneto, R. P., Herndon, R.M., and Mass, M.K, IIIrd International Symposium on Neural Transplantatio, Cambridge, England, 1/6/1989
• Demyelinating Antibodies Induced by Myelin Proteins
  Seil, F.J., Herndon, R.M., Agrawal, H.C, International Society for Developmental Neuroscience Meeting, Jerusalem, 1/1/1988
• The effects of enzymes on axonal structure and function
  Herndon, R.M, International workshop on functional consequences of demyelination, Quebec, Canada, 1/1/1988
• Osmotic demyelination syndrome (ODS): An experimental model
  Sterns, R.H., Thomas, D., Herndon, R.M, Am. Soc. Nephrology, 1/1/1988
• Synapse regulation by transplanted astrocytes: A tissue culture study
  Seil, F.J., Meshul, C.K. and Herndon, R.M, Schmitt Neurological Sciences Symposium: Transplantation into the Mammalian CNS. University of Rochester, Rochester, NY, 1/30/1987
• The effect of immunosuppressive drugs on remyelination
  Herndon, R.M. and Triarhou, L.C, Soc. Neurosci, 1/1/1985
• Triarhou, L.C. and Herndon, R.M, American Association of Neuropathologists, St. Louis, MO, 1/14/1984
• Immunoperoxidase labeling of rat brains with sera from patients with paraneoplastic cerebellar degeneration and systemic neoplasia
  Greenlee, J.E. and Herndon, R.M, American Association of Neuropathologists, San Diego, CA, 1/14/1984
• Myelin basic protein (MBP) as an early predictor of delayed radiation myelopathy in the rabbit model
  Good, R., Herndon, R., Maniscalco, W. and Rubin, P, American Society for Therapeutic Radiology and Oncology, Washington, DC, 1/7/1984
• Permanent method for simultaneous demonstration of astrocytes and oligodendrocytes
  del Cerro, C., Sternberger, N.H. and Herndon, R.M, 60th Annual Meeting of the American Association of Neuropathologists, 1/1/1984
• Performance factors in regard to impaired memory and tolerance induced by atropine sulfate
  Thomas, G.J., Kasckow, J.W. and Herndon, R.M, Soc. Neurosci, 1/1/1984
• Join now to see all

Other

• Multiple Sclerosis: Systems of Care and disease Management - editorial 
  Herndon, R.M., Presentations in Focus, summary of the 12th Annual CMSC Conference
  1/5/1997
• What we know, what we believe and what we don't know about MS 
  Herndon, R.M., MS Quarterly
  1/1/1994
• Millions of lives have been saved by research on animals 
  Herndon, R.M., Democrat & Chronicle
  Rochester, NY - 1/30/1985
• We need animals in the lab 
  Herndon, R.M, Washington Post
  1/14/1981
• Join now to see all